Growth Metrics

Zevra Therapeutics (ZVRA) Amortization - Intangibles (2023 - 2025)

Historic Amortization - Intangibles for Zevra Therapeutics (ZVRA) over the last 3 years, with Q3 2025 value amounting to $315000.0.

  • Zevra Therapeutics' Amortization - Intangibles fell 7961.17% to $315000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 424.78%. This contributed to the annual value of $6.2 million for FY2024, which is 70764.25% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Amortization - Intangibles of $315000.0 as of Q3 2025, which was down 7961.17% from $1.6 million recorded in Q2 2025.
  • Zevra Therapeutics' 5-year Amortization - Intangibles high stood at $1.6 million for Q4 2024, and its period low was $315000.0 during Q3 2025.
  • Over the past 3 years, Zevra Therapeutics' median Amortization - Intangibles value was $1.5 million (recorded in 2024), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Zevra Therapeutics' Amortization - Intangibles surged by 10932.64% in 2024, and later tumbled by 7961.17% in 2025.
  • Over the past 3 years, Zevra Therapeutics' Amortization - Intangibles (Quarter) stood at $772000.0 in 2023, then surged by 109.33% to $1.6 million in 2024, then tumbled by 80.51% to $315000.0 in 2025.
  • Its Amortization - Intangibles was $315000.0 in Q3 2025, compared to $1.6 million in Q2 2025 and $1.6 million in Q1 2025.